- Reports: Bill to extend federal regulations for compounding pharmacies expected to pass House, Senate
- NACDS RxImpact shines spotlight on pharmacists' increasing role in delivery of healthcare services
- FMI urges appellate court to uphold debit reform ruling
- Federal government should take wise approach to compounding regulations
- HDMA honors three legislators with Rx Safety and Healthcare Leadership Award
ARLINGTON, Va. As members of Congress move to try and force China to revalue its currency, the renminbi yuan, retailers are weighing in on the issue.
The Retail Industry Leaders Association, which represents more than 200 retailers, manufacturers and suppliers, asked lawmakers Friday to reject legislation under consideration Friday morning by the House Ways and Means Committee that would pressure China on its currency by imposing tariffs on products imported from there.
Alarge share of consumer products sold in the United States are made in China, and in many cases are no longer made in the United States. Thus, placing tariffs on goods imported from China could force retailers to pass the costs onto consumers.
“Provoking tension with our trading partners doesn’t come without costs, and we should choose our battles carefully, especially given the great amount of uncertainty in markets at this time,” RILA VP international trade Stephanie Lester said. “It makes little sense to enact harmful policies that will spark a bilateral conflict over currency with one of our largest trading partners and fastest-growing markets for American exports, given almost stagnant economic growth.”